Impact of PIP5K1 on extracellular vesicle biogenesis
Project Number1R03TR004480-01
Contact PI/Project LeaderTANIS, JESSICA E
Awardee OrganizationUNIVERSITY OF DELAWARE
Description
Abstract Text
Project Summary
Small secreted extracellular vesicles (EVs) play critical roles in communication between cells during
physiological and pathological processes. The primary cilium, a sensory organelle protruding from cells, serves
as a platform to transmit signals via shedding of microvesicles, a class of EVs that bud directly from the plasma
membrane. In C. elegans, microvesicles shed from sensory neuron cilia are discharged into the environment
where they play a role in animal-to-animal communication. We discovered that CLHM-1, the homolog of
Illuminating the Druggable Genome (IDG) target FAM26 ion channels, is a cargo in EVs released from the ciliary
base. tdTomato-tagged CLHM-1 and GFP-tagged PKD-2, a well described EV cargo and homolog of the IDG
target PKD2L2 TRPP channel, colocalize in the ciliary base and cilium middle segment. However, these proteins
are enriched in distinct EV subpopulations that are discharged in different quantities, with PKD-2 alone located
in the cilium distal tip and EVs shed from this site. CLHM-1 versus PKD-2 containing EVs are differentially shed
into the environment in response to the presence of mating partners, demonstrating that a single cilium can
release distinct subpopulations of microvesicles, each with different cargo enrichment and functionalities.
There is limited understanding of the mechanisms underlying microvesicle cargo loading, biogenesis and
release. The membrane lipid phosphatidylinositol 4,5-bisphosphate PI(4,5)P2 plays critical roles in protein
localization and cytoskeletal remodeling. While a few studies suggest that PI(4,5)P2 levels affect EV cargo
localization and biogenesis, it remains unclear whether PI(4,5)P2 promotes or inhibits microvesicle shedding.
PI(4,5)P2 is predominantly generated by type I phosphatidylinositol 4-phosphate 5-kinases (PIP5K1s), the IDG
target focus of this proposal. There is a single PIP5K1 in C. elegans, PPK-1. Our overarching goal is to draw
upon the strengths of our genetic model system and cutting edge imaging approaches to define how PIP5K1-
dependent generation of PI(4,5)P2 impacts EV cargo sorting and formation.
The proposed research will use our unique transgenic animals that express multiple fluorescently tagged EV
cargoes at single copy level and advanced imaging techniques to determine how overexpression of PPK-1 as
well as inducible loss of this kinase affects shedding of cilia-derived microvesicle subpopulations and
colocalization of cargoes in EVs. Using a a PI(4,5)P2 reporter consisting of the PH domain of PLCδ1 fused to
GFP we will define the impact of PPK-1 on PI(4,5)P2 ciliary abundance and localization. Finally, we will determine
if PPK-1 and PI(4,5)P2 subciliary localization underlies the differences in EV subpopulation abundance and
release in response to mating partner presence. This work will lead to an understanding of how PIP5K1 activity
impacts formation of heterogeneous EV populations with different physiological functions, impacting broadly on
our comprehension of EV biogenesis and cargo sorting mechanisms utilized in vivo.
Public Health Relevance Statement
Project Narrative
Small secreted extracellular vesicles enable communication between cells during physiological processes and
in pathological conditions including cancer progression and neurodegenerative diseases. This work will provide
an understanding of how type I phosphatidylinositol 4-phosphate 5-kinase (PIP5K1) control of membrane lipid
content affects the packaging and release of extracellular vesicles.
National Center for Advancing Translational Sciences
CFDA Code
310
DUNS Number
059007500
UEI
T72NHKM259N3
Project Start Date
01-July-2023
Project End Date
30-June-2024
Budget Start Date
01-July-2023
Budget End Date
30-June-2024
Project Funding Information for 2023
Total Funding
$155,771
Direct Costs
$100,000
Indirect Costs
$55,771
Year
Funding IC
FY Total Cost by IC
2023
NIH Office of the Director
$155,771
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03TR004480-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03TR004480-01
Patents
No Patents information available for 1R03TR004480-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03TR004480-01
Clinical Studies
No Clinical Studies information available for 1R03TR004480-01
News and More
Related News Releases
No news release information available for 1R03TR004480-01
History
No Historical information available for 1R03TR004480-01
Similar Projects
No Similar Projects information available for 1R03TR004480-01